Avalon Investment & Advisory Merck & Co., Inc. Transaction History

Avalon Investment & Advisory

$3.56 Billion
Q1 2023

A detailed history of Avalon Investment & Advisory transactions in Merck & Co., Inc. stock. As of the latest transaction made, Avalon Investment & Advisory holds 736,753 shares of MRK stock, worth $72.2 Million. This represents 2.2% of its overall portfolio holdings.

Number of Shares

736,753

Previous 756,392 2.6%

Holding current value

$72.2 Million

Previous $83.9 Million 6.6%

% of portfolio

2.2%

Previous 2.39%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$102.94 - $114.86 $2.02 Million - $2.26 Million	-19,639 Reduced 2.6%	736,753 $78.4 Million
Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $292,137 - $374,559	-3,341 Reduced 0.44%	756,392 $83.9 Million
Q3 2022 Nov 01, 2022	SELL	$84.53 - $94.96 $1.49 Million - $1.67 Million	-17,622 Reduced 2.27%	759,733 $65.4 Million
Q2 2022 Aug 10, 2022	BUY	$83.49 - $94.64 $207,890 - $235,653	2,490 Added 0.32%	777,355 $70.9 Million
Q1 2022 May 17, 2022	BUY	$73.51 - $82.4 $1.25 Million - $1.4 Million	17,034 Added 2.25%	774,865 $63.6 Million
Q4 2021 Feb 14, 2022	SELL	$72.28 - $90.54 $4.76 Million - $5.96 Million	-65,855 Reduced 8.0%	757,831 $58.1 Million
Q3 2021 Nov 08, 2021	SELL	$71.68 - $78.83 $406,784 - $447,360	-5,675 Reduced 0.68%	823,686 $61.9 Million
Q2 2021 Jul 29, 2021	BUY	$70.31 - $77.77 $7.6 Million - $8.41 Million	108,123 Added 14.99%	829,361 $64.5 Million
Q1 2021 May 13, 2021	SELL	$68.86 - $81.11 $21.1 Million - $24.9 Million	-306,995 Reduced 29.86%	721,238 $55.6 Million
Q4 2020 Feb 08, 2021	SELL	$71.77 - $79.65 $1.6 Million - $1.78 Million	-22,308 Reduced 2.12%	1,028,233 $84.1 Million
Q3 2020 Nov 04, 2020	SELL	$73.18 - $82.95 $4.5 Million - $5.1 Million	-61,442 Reduced 5.53%	1,050,541 $87.1 Million
Q2 2020 Aug 07, 2020	SELL	$70.42 - $80.13 $6.26 Million - $7.12 Million	-88,825 Reduced 7.4%	1,111,983 $86 Million
Q1 2020 May 05, 2020	SELL	$63.36 - $87.82 $6.97 Million - $9.67 Million	-110,082 Reduced 8.4%	1,200,808 $92.4 Million
Q4 2019 Feb 14, 2020	BUY	$77.58 - $87.54 $1.65 Million - $1.86 Million	21,216 Added 1.65%	1,310,890 $119 Million
Q3 2019 Nov 14, 2019	BUY	$76.08 - $82.93 $798,459 - $870,350	10,495 Added 0.82%	1,289,674 $109 Million
Q2 2019 Aug 14, 2019	BUY	$69.84 - $81.59 $8.58 Million - $10 Million	122,851 Added 10.62%	1,279,179 $107 Million
Q1 2019 Apr 24, 2019	BUY	$69.58 - $79.36 $1.75 Million - $2 Million	25,159 Added 2.22%	1,156,328 $96.2 Million
Q4 2018 Feb 14, 2019	BUY	$65.24 - $75.71 $13.5 Million - $15.6 Million	206,512 Added 22.33%	1,131,169 $86.4 Million
Q3 2018 Nov 14, 2018	BUY	$57.69 - $67.84 $1 Million - $1.18 Million	17,384 Added 1.92%	924,657 $65.6 Million
Q2 2018 Aug 14, 2018	BUY	$50.83 - $59.72 $4.25 Million - $4.99 Million	83,577 Added 10.15%	907,273 $55.1 Million
Q1 2018 Jun 26, 2018	BUY	$50.96 - $59.23 $7.64 Million - $8.88 Million	149,898 Added 22.25%	823,696 $44.9 Million
Q1 2018 Jun 22, 2018	SELL	$50.96 - $59.23 $8.4 Million - $9.76 Million	-164,823 Reduced 19.65%	673,798 $37.9 Million
Q1 2018 May 15, 2018	BUY	$50.96 - $59.23 $8.4 Million - $9.76 Million	164,823 Added 24.46%	838,621 $45.7 Million
Q4 2017 Jun 22, 2018	SELL	$51.62 - $61.64 $1.37 Million - $1.64 Million	-26,617 Reduced 3.8%	673,798 $37.9 Million
Q4 2017 Feb 14, 2018	SELL	$51.62 - $61.64 $1.78 Million - $2.12 Million	-34,432 Reduced 4.69%	700,415 $39.4 Million
Q3 2017 Nov 14, 2017	SELL	$58.67 - $63.13 $42.8 Million - $46.1 Million	-729,904 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	729,904	729,904 $46.8 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avalon Investment & Advisory, based on Form 13F filings with the SEC.

News

Stay updated on Avalon Investment & Advisory with notifications on news.

Account

Avalon Investment & Advisory Merck & Co., Inc. Transaction History